Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Mesothelioma, Malignant 2Colorectal Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma, Synovial 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Liposarcoma, Myxoid 1Kidney Neoplasms 1Infections 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

fludarabine phosphate 17Mycophenolic Acid 17Tacrolimus 15Peripheral Blood Stem Cell Transplantation 14Whole-Body Irradiation 13Cyclophosphamide 12Cyclosporine 11Methotrexate 10Antilymphocyte Serum 10Busulfan 9Radiotherapy 6pembrolizumab 5Methylprednisolone 5Alemtuzumab 5merphos 4Transplantation 4Rituximab 4Melphalan 4Flow Cytometry 4Cord Blood Stem Cell Transplantation 4Bexarotene 4sargramostim 3Therapeutics 3Sirolimus 3Panobinostat 3Lenalidomide 3Gemcitabine 3Dexamethasone 3Cyclosporins 3zanolimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sezary Syndrome × Interferon-gamma × Clear all
NCT03063632 2023-10-25

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
28 enrolled 15 charts
LymphoidSarcoma

Mycosis Fungoides, Sezary Syndrome, Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡